dengue
Beating Dengue Is In Your DNA (Vaccine)
A DNA-based vaccine against dengue, which would not require cold chain transport, has been shown to protect mice against two out of the four strains of dengue virus.
7 Must-Read Stories In June 2017
Climate change, solar energy and disease were key issues in the month of June.
7 In 10 Indonesian Children Exposed To Dengue
In a study conducted on more than 3,000 Indonesian children from ages one to 18, nearly 70 percent tested positive for dengue antibodies, an indication that they have been infected before.
Teaching Old Tools New Tricks
An ‘old’ cancer detection technology is now being explored as a dengue detection tool in humans.
Going Anti-Dengue With Antibodies
Therapeutic antibodies offer promising new options for treating infectious diseases, including dengue, writes immunologist Dr Katja Fink.
Daily Platelet Counts Predict Kids’ Risk Of Dengue Shock Syndrome
In a new study from Vietnam, daily platelet counts helped to identify patients who went on to develop dengue shock syndrome, a potentially lethal complication of dengue infection.
How The Dengue Virus Opens Up To Human Hosts
The change in temperature when dengue viruses enter a human from a mosquito host cause structural changes that expose weak spots.
Promising Results For Takeda’s Dengue Vaccine
Takeda's dengue vaccine has proven to be safe and able to produce an antibody response against all four serotypes of dengue in an interim analysis of their ongoing Phase 2 trial.
A*STAR & Chugai’s Anti-Dengue Antibody Project Receives GHIT Funding
The Global Health Innovative Technology Fund has awarded a US$5.3 million grant to help develop an antibody that can neutralize all four dengue serotypes.
